// App-Quantinova.ai

: Acquired Hemophilia A with an Exorbitant Inhibitor and Venous Thrombosis: Successfull Treatment with Recombinant Porcine FVIII Plus Recombinant FVIIa and Immediate Anti‐CD20 Therapy

Researchers

Presenter

  • M. Herma

Principal Investigators

  • L. Graf

  • S. Endermann

  • W. Korte

Medical Centers

  • Haemostasis‐ and Haemophilia Center St. Gallen, Center for Laboratory Medicine, St. Gallen, Switzerland

  • Kantonsspital St Gallen, St Gallen, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Hemophilia

Biomarkers

  • Activated factor VII

  • B-lymphocyte antigen CD20

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved